Pseudomonas aeruginosa is an uncommon cause of bacteremia upon hospital admission
(UHA) and the chosen empirical antimicrobial therapy may not cover it appropriately. In a …

Among the nosocomial pathogens, Pseudomonas aeruginosa is recognized as a major
cause of morbidity and mortality. Data on 136 patients with P. aeruginosa bacteremia were …

This study was performed to identify the risk factors for mortality and evaluate the effect of
inappropriate initial antimicrobial therapy on the outcomes of patients with community-onset …

BACKGROUND: Pseudomonas aeruginosa bacteremia is a serious and possibly fatal
condition. It is important to determine the likelihood of P. aeruginosa bacteremia when Gram …

The impact of appropriate empirical antimicrobial therapy for Pseudomonas aeruginosa
bacteremia on patient outcomes has not been clearly established. We assessed the effect of …

In a retrospective study, population characteristics and outcome were investigated in
intensive care unit (ICU) patients with hospital-acquired Pseudomonas aeruginosa …

Background. Pseudomonas aeruginosa is an uncommon cause of community-acquired
bacteremia among patients without severe immunodeficiency. Because tension exists …

Inadequate empirical antibiotic therapy for serious Pseudomonas aeruginosa infections has
been linked to increased mortality. We performed a retrospective cohort study of consecutive …

Objective The mortality rates for bacteremia due to Pseudomonas aeruginosa remain high.
In our hospital, we performed retrospective analyses to determine risk factors for mortality …

Pseudomonas aeruginosa previously has been reviewed in “Topics in Clinical
Microbiology.” However, the increased importance of this micro-organism in nosocomial …